Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for hemodynamics and postoperative cognition in elderly hypertensive patients undergoing laparoscopic cholecystectomy
ChiCTR2500100125Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Longquanyi District, Chengdu
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in hypertension (HTN) and cholelithiasis (2 arms), sponsored by The First People's Hospital of Longquanyi District, Chengdu. Primary endpoint: Incidence of hypotension during anesthesia induction. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypertension (HTN)cholelithiasis
Beyond the preview
Go deeper on ChiCTR2500100125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100125.